These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36786337)
1. Atopic status and thyroid autoimmunity do not predict omalizumab response in severe chronic spontaneous urticaria patients. Asero S Eur Ann Allergy Clin Immunol; 2024 May; 56(3):141-143. PubMed ID: 36786337 [No Abstract] [Full Text] [Related]
2. Total IgE and atopic status in patients with severe chronic spontaneous urticaria unresponsive to omalizumab treatment. Asero R; Ferrucci S; Casazza G; Marzano AV; Cugno M Allergy; 2019 Aug; 74(8):1561-1563. PubMed ID: 30801715 [No Abstract] [Full Text] [Related]
3. Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response? Asero R; Ferrucci SM; Calzari P; Consonni D; Cugno M Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108654 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of patients with chronic spontaneous urticaria showing early and complete responses to omalizumab. Cho YT; Fu KT; Yang CW; Chu CY Ann Allergy Asthma Immunol; 2021 Sep; 127(3):394-395. PubMed ID: 34102302 [No Abstract] [Full Text] [Related]
5. Omalizumab in severe chronic urticaria: are slow and non-responders different? Asero R Eur Ann Allergy Clin Immunol; 2021 Nov; 53(6):263-266. PubMed ID: 32914943 [No Abstract] [Full Text] [Related]
6. Clinical variables of severe chronic spontaneous urticaria from total IgE standpoint: a retrospective study. Asero R Eur Ann Allergy Clin Immunol; 2022 Jan; 54(1):30-33. PubMed ID: 33555151 [No Abstract] [Full Text] [Related]
7. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria. Skander D; Allenova A; Maurer M; Kolkhir P Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030 [No Abstract] [Full Text] [Related]
8. Efficacy of omalizumab in chronic spontaneous urticaria associated with chronic inducible urticaria. Dortas Junior S; Azizi G; Valle S Ann Allergy Asthma Immunol; 2020 Oct; 125(4):486-487. PubMed ID: 32544531 [No Abstract] [Full Text] [Related]
9. H1-Antihistamines May No Longer Be Necessary for Patients With Refractory Chronic Spontaneous Urticaria After Initiation of Omalizumab. Ensina LF; Arruda LK; Campos RA; Criado RF; Rodrigues Valle S; Melo JM; Oliveira JC; Dortas JS; Cusato-Ensina AP; Camelo-Nunes IC; Agondi RC J Investig Allergol Clin Immunol; 2020 Apr; 30(2):145-147. PubMed ID: 31762438 [No Abstract] [Full Text] [Related]
10. Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count. Tamer F; Gulru Erdogan F; Dincer Rota D; Yildirim D; Akpinar Kara Y Acta Dermatovenerol Croat; 2019 Jun; 27(2):101-106. PubMed ID: 31351504 [TBL] [Abstract][Full Text] [Related]
11. Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria. Costa C; Esteves Caldeira L; Paulino M; Santos DF; Silva SL Int Arch Allergy Immunol; 2024; 185(3):260-266. PubMed ID: 38113870 [TBL] [Abstract][Full Text] [Related]
12. The use of omalizumab for treatment-refractory chronic spontaneous urticaria in a West Australian outpatient cohort. Farrah G; Stevenson B; Lie K; Brusch A Intern Med J; 2019 Apr; 49(4):526-528. PubMed ID: 30957371 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria. Belbezier A; Boccon-Gibod I; Bouillet L Eur J Dermatol; 2021 Feb; 31(1):86-87. PubMed ID: 33772528 [No Abstract] [Full Text] [Related]
14. Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis. Holm JG; Sørensen JA; Thomsen SF Int J Dermatol; 2022 May; 61(5):e173-e174. PubMed ID: 34813086 [No Abstract] [Full Text] [Related]
15. Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence. Tonacci A; Nettis E; Asero R; Rossi O; Tontini C; Gangemi S Eur Ann Allergy Clin Immunol; 2020 May; 52(3):100-103. PubMed ID: 32108461 [TBL] [Abstract][Full Text] [Related]
16. Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice. Vollono L; Piccolo A; Lanna C; Esposito M; Bavetta M; Campione E; Bianchi L; Diluvio L Drug Des Devel Ther; 2019; 13():3181-3186. PubMed ID: 31564834 [TBL] [Abstract][Full Text] [Related]